セプシスのベースラインのプラズマDダイマー濃度の予測値: 予見的なコホート研究
Xiaoxiao Qu1, Shishi Wang1, Xuanmei Ye1
1Department of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
Practical laboratory medicine
|September 2, 2025
まとめ
入院時のプラズマD- ダイマー濃度は,セプシス患者における30日間の死亡率と結血ショックを予測する. D- ダイマーの高さはリスクの上昇を示し,早期のセプシス管理とリスクの階層化を助けます.
科学分野:
- クリティカル ケア 医療
- 血液学
- バイオマーカー
背景:
- 線維素の分解産物であるプラズマDジメールは凝固の活性化を示し,重症患者ではしばしば上昇する.
- セプシスの短期的な結果に対するD- ダイマーの予後値は十分に確立されていません.
研究 の 目的:
- セプシスを持つ成人ICU患者における短期的なアウトカムに対するプラズマDダイマー濃度の予後的意義を調査する.
- D-ダイマーがセプシスの管理におけるリスク層分化の初期バイオマーカーとして機能するかどうかを判断する.
主な方法:
- 予期的なコホート研究では,セプシスと診断された175人の成人ICU患者 (セプシス-3基準) が参加しました.
- プラズマのD- ダイマー濃度はICUに入院時に測定され,5日間毎日測定された.
- 評価対象は,コックス回帰とカプラン- メイヤー分析を用いた30日全因死亡率と入院性 сепティックショックでした.
主要な成果:
- D- ダイマー濃度の上昇は,30日間の死亡率とセプティックショックのリスクの増加と有意に関連していました.
- D- ダイマーが1μg/ ml増加すると,死亡リスクが6%高くなり (HR=1. 06) 結核ショックのリスクが8%高くなり (HR=1. 08).
- D- ダイマーと血清アミロイドA (SAA) の間で死亡率の有意な相互作用が観察されました.
結論:
- 血のD- ダイマー濃度は,セプシス患者における30日間の死亡率とセプティックショックを独立して予測する.
- D-ジメルは,セプシスの管理におけるリスクの階層化のための貴重な早期のバイオマーカーとしての可能性を示しています.
- D-ディメールのセプシスの治療介入の指針としての役割については,さらなる研究が行われる可能性がある.
さらに関連する動画
関連する概念動画
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Pulmonary Embolism III: Nursing Management
37
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
37
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57


